From May 11, 2022 to June 30, 2022, the company has repurchased 175,000 shares, representing 0.46% for ¥646.02 million. With this, the company has completed the repurchase of 175,000 shares, representing 0.46% for ¥646.02 million under the buyback announced on May 11, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,451 JPY | +0.23% | -1.96% | +2.86% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.86% | 841M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- 4521 Stock
- News Kaken Pharmaceutical Co., Ltd.
- Tranche Update on Kaken Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.